Skip to main content
OpenTrials
Completed

NCT Number: NCT06785896

Analysis of the Effect oh the Carriere Motion 3D

Class II subdivision malocclusions are common and complex to treat due to their asymmetry. The range of orthodontic correction devices is expanding towards systems that are more comfortable for the patient but may not necessarily have scientific evidence to demonstrate their effectiveness. The aim of this study was therefore to evaluate, for the first time, the effect of a Class II correction device, namely the Carriere Motion 3D (CMA), on patients with a Class II subdivision malocclusion. Method:this retrospective observational study included all patients presenting with a Class II subdivision malocclusion and treated with CMA between July 2018 and November 2023. Before treatment (T0) and after treatment with CMA (T1), orthodontic data from dental molds and lateral cephalometric radiographs (Steiner analysis) were collected and statistically analyzed to assess dentoalveolar as well as skeletal effects of treatment using CMA."

Completed

Looking for future studies?

Notify Me

Key information

Age range

28 year–47 year

Sex eligibility

All sexes

Study type

Observational

Primary location

CHU NICE

Nice, Alpes Maritimes, 0600, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients who have completed their growth and present with a Class II subdivision malocclusion.
  • Patients who underwent orthodontic treatment with CMA between 07/11/2018 and 11/22/2023.
  • Patients who have a complete orthodontic record allowing for pre- and post-treatment measurements with CMA.

Exclusion criteria

None

Treatment and study plan

Angle Class II unilateral, treated by carriere motion appliance

Procedure

This treatment was unilateral, with dental composite bites ramps behind canines

Primary outcomes

  1. Molar Angle class II correction

    Time frame: Up to 6 months

    Measured between the centro vestibular groove of the maxillar fisrt molar and the mesio vestibulair cusp tip of the mandibular molar in millimeters

Secondary outcomes

  1. Canine Angle class II correction

    Time frame: Up to 6 months

    Measurement performed between the maxillary canine cusp tip and the inter-dental space between the mandibular canine and premolar in millimeters

  2. Extrusion or intrusion

    Time frame: Up to 6 months

    Extrusion or intrusion of the maxillary canines and molars supporting the orthodontic appliance in millimeters

  3. Correction of the Class II canine relationship

    Time frame: Up to 6 months

    Mesured correction of the Class II canine relationship in millimeters

  4. Rotations

    Time frame: Up to 6 months

    Mesured of the Rotations of the molars and canines supporting the CMA in degrees

  5. Inter-incisal variations

    Time frame: Up to 6 months

    Mesure of the variation in the inter-incisal midline discrepancy in millimeters

  6. Arch depth

    Time frame: Up to 6 months

    Mesure of the variation in arch depth in millimeters

  7. Arch width

    Time frame: Up to 6 months

    Mesure of th variation in canine and molar arch width in millimeters

  8. Steiner analysis

    Time frame: Up to 24 months

    A Steiner analysis was performed on the lateral cephalograms, measurements in millimeters on the X-Ray

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire de Nice

Other

Registry information

Official study title

Analysis of the Effect oh the Carriere Motion 3D on Patients With Class II Subdivision : a Retrospective Study

Important dates

Study start
2018
Primary completion
2023
Study completion
2023
First posted
Jan 21, 2025
Registry last updated
Jan 21, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.